A pharmaceutical plant that was producing ingredients for Covid-19 vaccines developed by both AstraZeneca and Johnson & Johnson will exclusively supply the latter company after a mistake by workers spoiled millions of doses.
US-based J&J
Biopharmaceutical company Emergent BioSolutions, where a mishap spoiled 15m doses of Johnson & Johnson's Covid-19 vaccine. Photo / Getty Images
A pharmaceutical plant that was producing ingredients for Covid-19 vaccines developed by both AstraZeneca and Johnson & Johnson will exclusively supply the latter company after a mistake by workers spoiled millions of doses.
US-based J&J
Tame talks to Liam Dann about broadcasting and Christchurch's obsession with schools